Submitted by Anonymous (not verified) on 11 March 2026 - 11:32
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 20, Status: Authorised